Adage Capital Partners GP L.L.C. Grows Position in LifeStance Health Group, Inc. $LFST

Adage Capital Partners GP L.L.C. lifted its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 43.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 230,000 shares of the company's stock after buying an additional 70,000 shares during the quarter. Adage Capital Partners GP L.L.C. owned approximately 0.06% of LifeStance Health Group worth $1,532,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. DekaBank Deutsche Girozentrale purchased a new stake in shares of LifeStance Health Group during the first quarter worth approximately $31,000. Xponance Inc. purchased a new stake in shares of LifeStance Health Group during the first quarter worth approximately $69,000. Ameriprise Financial Inc. purchased a new stake in shares of LifeStance Health Group during the fourth quarter worth approximately $87,000. Kapitalo Investimentos Ltda purchased a new stake in shares of LifeStance Health Group during the first quarter worth approximately $87,000. Finally, Forum Financial Management LP purchased a new stake in shares of LifeStance Health Group during the fourth quarter worth approximately $110,000. 85.50% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently commented on the company. UBS Group boosted their price target on LifeStance Health Group from $8.50 to $9.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Wall Street Zen upgraded LifeStance Health Group from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Finally, BTIG Research assumed coverage on LifeStance Health Group in a research report on Friday, July 25th. They set a "buy" rating and a $8.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, LifeStance Health Group currently has a consensus rating of "Moderate Buy" and an average price target of $8.50.

LifeStance Health Group Trading Down 2.1%

NASDAQ:LFST traded down $0.11 during trading hours on Friday, hitting $5.23. The company had a trading volume of 1,246,590 shares, compared to its average volume of 2,071,969. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.19. The company has a 50-day moving average of $4.81 and a 200 day moving average of $5.74. The company has a market cap of $2.03 billion, a P/E ratio of -104.60 and a beta of 1.17. LifeStance Health Group, Inc. has a 1 year low of $3.74 and a 1 year high of $8.61.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.02. The company had revenue of $345.31 million during the quarter, compared to analysts' expectations of $345.05 million. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The firm's quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.06) EPS. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Sell-side analysts expect that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.

Insider Transactions at LifeStance Health Group

In other news, major shareholder Summit Partners L. P sold 8,407,643 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the transaction, the insider directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. This represents a 20.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Darren M. Black sold 8,407,643 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total value of $42,626,750.01. Following the transaction, the director owned 33,524,715 shares of the company's stock, valued at approximately $169,970,305.05. This represents a 20.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 20,407,643 shares of company stock worth $103,466,750. 3.20% of the stock is currently owned by company insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.